Literature DB >> 18449062

Correlation between respiratory syncytial virus (RSV) test data and hospitalization of children for RSV lower respiratory tract illness in Florida.

Michael Light1, Jay Bauman, Kunjana Mavunda, Frank Malinoski, Mark Eggleston.   

Abstract

BACKGROUND: Florida experiences year-round outbreaks of respiratory syncytial virus (RSV), but it is unknown if there is a correlation between RSV virology data and disease-related hospitalizations. We analyzed RSV surveillance and hospitalization data for the state of Florida to determine if there is an association between seasonal virology data and the incidence of International Classification of Diseases, 9th revision, clinical modification (ICD-9-CM) coded hospitalizations for RSV lower respiratory tract illness.
METHODS: We conducted a retrospective analysis for each of 5 regions of Florida for 4 years (2001-2004) of monthly RSV surveillance data presented on the Florida Department of Health website and hospitalization data provided by the Agency for Health Care Administration. RSV was considered present when > or =10% of laboratory tests were positive in a given month and the duration of seasons was determined by the number of consecutive months threshold values were exceeded. Hospitalizations in children 24 months of age and younger were defined as RSV related if any of the following RSV-specific ICD-9-CM codes appeared on the discharge summary: 079.6 RSV; 466.11 acute bronchiolitis caused by RSV; and 480.1 pneumonia caused by RSV.
RESULTS: RSV circulated year-round statewide and seasons ranged from 7-8 months in the southwest, northwest, and north regions of Florida to 11-12 months in the central and southeast regions, respectively. More than 23,000 children younger than 24 months of age were hospitalized throughout the state for an RSV-related illness during the 4-year period, with almost 20,000 (86%) of the admissions in infants less than 12 months of age. There were 23 hospitalizations yearly per 1000 births and more than 90% of discharges occurred during the defined RSV seasons.
CONCLUSIONS: To our knowledge, this is the first study to demonstrate a positive correlation between RSV test data and hospitalizations both statewide and for individual regions within Florida. It would be prudent for clinicians to obtain results of local RSV virology data to guide decisions on timing of prophylaxis to prevent RSV hospitalizations.

Entities:  

Mesh:

Year:  2008        PMID: 18449062     DOI: 10.1097/INF.0b013e318168daf1

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

1.  Efficacy and optimization of palivizumab injection regimens against respiratory syncytial virus infection.

Authors:  Alexander Gutfraind; Alison P Galvani; Lauren Ancel Meyers
Journal:  JAMA Pediatr       Date:  2015-04       Impact factor: 16.193

2.  Summer Outbreak of Severe RSV-B Disease, Minnesota, 2017 Associated with Emergence of a Genetically Distinct Viral Lineage.

Authors:  Beth K Thielen; Erica Bye; Xiong Wang; Stacene Maroushek; Hannah Friedlander; Sarah Bistodeau; Jaime Christensen; Erik Reisdorf; Meghan H Shilts; Karen Martin; Kathryn Como-Sabetti; Anna K Strain; Patricia Ferrieri; Ruth Lynfield
Journal:  J Infect Dis       Date:  2020-06-29       Impact factor: 5.226

3.  Respiratory syncytial virus hospitalization trends in infants with chronic lung disease of infancy, 1998-2008.

Authors:  Jessie R Groothuis; Jon P Fryzek; Doris Makari; Duane Steffey; William J Martone
Journal:  Clin Epidemiol       Date:  2011-09-29       Impact factor: 4.790

4.  Palivizumab compliance by infants in Puerto Rico during the 2009-2010 respiratory syncytial virus season.

Authors:  Israel Matías; Inés García-García; Lourdes García-Fragoso; Marta Valcárcel
Journal:  J Community Health       Date:  2014-12

5.  Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United States.

Authors:  Virginia E Pitzer; Cécile Viboud; Wladimir J Alonso; Tanya Wilcox; C Jessica Metcalf; Claudia A Steiner; Amber K Haynes; Bryan T Grenfell
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

Review 6.  Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis.

Authors:  Renato T Stein; Louis J Bont; Heather Zar; Fernando P Polack; Caroline Park; Ami Claxton; Gerald Borok; Yekaterina Butylkova; Colleen Wegzyn
Journal:  Pediatr Pulmonol       Date:  2016-10-14

7.  Demonstrating the use of high-volume electronic medical claims data to monitor local and regional influenza activity in the US.

Authors:  Cécile Viboud; Vivek Charu; Donald Olson; Sébastien Ballesteros; Julia Gog; Farid Khan; Bryan Grenfell; Lone Simonsen
Journal:  PLoS One       Date:  2014-07-29       Impact factor: 3.240

8.  Respiratory syncytial virus seasonality in Brazil: implications for the immunisation policy for at-risk populations.

Authors:  André Ricardo Ribas Freitas; Maria Rita Donalisio
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-03-29       Impact factor: 2.743

9.  Respiratory syncytial virus activity--United States, July 2011-January 2013.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-03-01       Impact factor: 17.586

10.  Respiratory syncytial virus tracking using internet search engine data.

Authors:  Eyal Oren; Justin Frere; Eran Yom-Tov; Elad Yom-Tov
Journal:  BMC Public Health       Date:  2018-04-03       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.